ArticleCancer immunology, immunotherapy : CII2016

Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance.

Francisco Javier Carretero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.